Timothy P. Lynch’s Stonepine Capital Portfolio: Top 5 Healthcare Stocks
In this article, we discuss the top 5 healthcare stock picks of Timothy P. Lynch's Stonepine Capital.
Posts Tagged ‘NASDAQ:ADMS’
5 Pharmaceutical Stocks to Buy According to Timothy Lynch’s Stonepine Capital
In this article, we will discuss the 5 pharmaceutical stocks to buy according to Timothy Lynch's Stonepine Capital based on Q2 2021 holdings of the fund.
Adamas Pharmaceuticals Inc (ADMS): Hedge Funds Are Snapping Up
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need ...
Is ADMS A Good Stock To Buy Now?
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Is Adamas Pharmaceuticals Inc (ADMS) A Good Stock To Buy ?
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Hedge Funds Are Dumping Adamas Pharmaceuticals Inc (ADMS)
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts, usually don't make them change...
Is Adamas Pharmaceuticals Inc (ADMS) A Good Stock To Buy?
Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings.
Market Movers Today: Switch Inc (SWCH), Longfin Corp (LFIN), Cellectis SA (ADR) (CLLS), Adamas Pharmaceuticals Inc (ADMS), and More
What happened: Shares of Switch (NYSE:SWCH) have gotten crushed today, down by 16% as of 12:20 p.m. EDT, after the data center specialist reported fourth-quarter earnings.
Market Movers Today: Immersion Corporation (IMMR), Trade Desk Inc (TTD), Blue Buffalo Pet Products Inc (BUFF), and More
What happened: Shares of Immersion Corporation (NASDAQ:IMMR) have surged today, up by 13% as of 11:20 a.m. EST, after it reported fourth-quarter earnings last night.
13G Filing: Kerrisdale Capital and Adamas Pharmaceuticals Inc (ADMS)
Please follow Kerrisdale Capital (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Kerrisdale Capital or update its stock holdings...
13G Filing: Point72 Asset Management and Adamas Pharmaceuticals Inc (ADMS)
Please follow Point72 Asset Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Point72 Asset Management or update its...
13G Filing: Great Point Partners and Adamas Pharmaceuticals Inc (ADMS)
Please follow Great Point Partners (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Great Point Partners or update its stock...
13G Filing: Armistice Capital and Adamas Pharmaceuticals Inc (ADMS)
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent...
Adamas Pharmaceuticals Inc (ADMS) Is Up On PDUFA: What’s Next?
Adamas Pharmaceuticals Inc (NASDAQ:ADMS) is up close to 15% on its 2017 open, on the back of a couple of positive developments out of its Parkinson’s disease pipeline.
Is Adamas Pharmaceuticals Inc (ADMS) A Good Stock To Buy?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
This Biotech Hedge Fund’s Stock Picks Killed It in Q3
Hedge funds returned about 4% so far this year and underperformed the S&P 500 Index again.
5 Healthcare Stocks Near the Top of Cheyne Capital’s Portfolio
London-based Cheyne Capital recently disclosed its U.S. equity portfolio via a 13F filing submitted with the SEC.
Two Big Parkinson’s Updates From Adamas Pharmaceuticals Inc (ADMS) And Acorda Therapeutics Inc (ACOR)
We just got a couple of updates in the Parkinson’s space, and both have the potential to serve up some volatility in the market capitalisations of the companies in question.
Taking A Look At Adamas Pharmaceuticals Inc (ADMS)’s Upcoming Parkinson’s NDA
Adamas Pharmaceuticals Inc (NASDAQ:ADMS) just announced its intention to submit an NDA for its lead Parkinson’s candidate before the year draws to a close.
Why Are These Four Stocks in The Spotlight Today?
With all three indexes roughly flat in morning trading as many veteran market participants kick back for the holidays and the rookies try to hold the fort, California Resources...
Small-Cap Healthcare Stocks That Insiders Are Buying
Over the past couple of days, the healthcare sector has witnessed plenty of insider activity, which should not be overlooked.
